David Gutmann, MD, PhD, FAAN (Co-Chair)

Washington University School of Medicine

David H. Gutmann received his MD and PhD from the University of Michigan, where he trained in immunogenetics with Dr. John Niederhuber. During his residency in Neurology at the University of Pennsylvania, he worked with Dr. Kenneth Fischbeck in neurogenetics. He received research fellowship training in Human Genetics with Dr. Francis Collins, where he identified the neurofibromatosis type 1 (NF1) protein and began to elucidate its function as a RAS regulator. Dr. Gutmann is currently the Donald O. Schnuck Family Professor, Vice Chair for Research Affairs in Neurology, and Director of the Washington University Neurofibromatosis Center. His laboratory is focused on understanding the genomic, molecular and cellular basis for nervous system problems affecting children and adults with NF1 using both human induced pluripotent stem cells and novel genetically engineered mouse strains. They have used these models to define the cellular origins of tumors, the contribution of the tumor microenvironment, and the major growth control pathways that dictate brain development in NF. Moreover, the use of NF1 as an experimental model system has revealed numerous insights into the basic neurobiology of human disease, including tumor-stroma dependencies in the cancer ecosystem, the impact of the germline mutation on phenotypic expression, the role of sexual dimorphism in clinical outcome, and the mechanisms underlying cell type-specific, brain region-distinct, and signaling pathway diversity. Dr. Gutmann has published over 465 peer-reviewed manuscripts, and has been recognized for his achievements with numerous awards, 

including the 2012 Children’s Tumor Foundation Frederich von Recklinghausen Lifetime

Achievement Award, the 2013 Washington University Distinguished Faculty Research Award, the 2014 Riley Church Lectureship, the 2017 Alexander von Humboldt Award, the 2019 Society for Neuro-Oncology Abhijit Guha Award, the 2020 National Neurofibromatosis Network Advocate of Hope Award, and the 2020 American Academy of Neurology Neuro-Oncology Investigator Award. He recently completed his tenure as a member of the National Institute of Neurological Disorders and Stroke Advisory Council.

Sessions